Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Pentasa
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pentasa 500mg modified-release tablets
0105010B0BCACAI
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 32,055 |
|
Pentasa 1g modified-release tablets
0105010B0BCAGAY
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 25,265 |
|
Pentasa 2g modified-release granules sachets
0105010B0BCAFAT
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 15,053 |
|
Pentasa 1g suppositories
0105010B0BCADAJ
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 12,525 |
|
Pentasa 1g modified-release granules sachets
0105010B0BCAEAN
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 9,037 |
|
Pentasa 4g modified-release granules sachets
0105010B0BCAHBA
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 2,585 |
|
Pentasa Mesalazine 1g/100ml enema
0105010B0BCAAAC
|
Pentasa | Mesalazine (Systemic) | Gastro-Intestinal System | 1,359 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.